We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
Sanctuary Advisors LLC cut its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 57.9% ...
Takeda Pharmaceutical teamed up with the Boston Celtics to raise awareness of rare diseases at the C’s-Cavaliers game on ...
An in-depth analysis of 50+ companies and 65+ pipeline drugs shaping the Molecular Glue market. The report covers therapeutics assessment by product type, development stage, route of administration, ...
Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...
The positive results of the Phase 3 VERIFY study across the primary and all key secondary endpoints provide compelling evidence of the potential for rusfertide as a first-in-class ...
GlobalData on MSN6d
Takeda broadens its deal with BridGene for up to $770mThe company highlighted that about 90% of proteins associated with diseases cannot be targeted with traditional therapies due ...
TOKYO -- Takeda Pharmaceutical aims to sell a vaccine for dengue in Japan as more business travelers go to Southeast Asian and Latin American destinations where the mosquito-borne viral disease is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback